Doshi, IN
Gautam Doshi, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20140040543 | Providing State Storage in a Processor for System Management Mode - In one embodiment, the present invention includes a processor that has an on-die storage such as a static random access memory to store an architectural state of one or more threads that are swapped out of architectural state storage of the processor on entry to a system management mode (SMM). In this way communication of this state information to a system management memory can be avoided, reducing latency associated with entry into SMM. Embodiments may also enable the processor to update a status of executing agents that are either in a long instruction flow or in a system management interrupt (SMI) blocked state, in order to provide an indication to agents inside the SMM. Other embodiments are described and claimed. | 02-06-2014 |
Gautam B. Doshi, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120002675 | PROVIDING A BUFFERLESS TRANSPORT METHOD FOR MULTI-DIMENSIONAL MESH TOPOLOGY - In one embodiment, the present invention includes a method for determining whether a packet received in an input/output (I/O) circuit of a node is destined for the node and if so, providing the packet to an egress queue of the I/O circuit and determining whether one or more packets are present in an ingress queue of the I/O circuit and if so, providing a selected packet to a first or second output register according to a global schedule that is independent of traffic flow. Other embodiments are described and claimed. | 01-05-2012 |
20140050224 | PROVIDING A BUFFERLESS TRANSPORT METHOD FOR MULTI-DIMENSIONAL MESH TOPOLOGY - In one embodiment, the present invention includes a method for determining whether a packet received in an input/output (I/O) circuit of a node is destined for the node and if so, providing the packet to an egress queue of the I/O circuit and determining whether one or more packets are present in an ingress queue of the I/O circuit and if so, providing a selected packet to a first or second output register according to a global schedule that is independent of traffic flow. Other embodiments are described and claimed. | 02-20-2014 |
Hiteshkumar Anilkant Doshi, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20100183730 | High dose composition of ursodeoxycholic acid - The present invention relates to high dose multiparticulate pharmaceutical formulation comprising ursodeoxycholic acid for oral administration, as well as a method for preparing said composition. | 07-22-2010 |
Jatin Doshi, Pune IN
Patent application number | Description | Published |
---|---|---|
20130060787 | CASE ANALYSIS SYSTEM - Systems and methods for cases based analysis are described. In one implementation, a new case-based document having static attributes and dynamic attributes is received. Once the static and the dynamic attributes are received, the static attributes of the received new case-based document is compared with the static attributes of one or more previously processed case-based documents. Based on the comparison, a sub-set of case-based documents is generated. For the generated sub-set, the dynamic attributes of the new case-based document are compared with the dynamic attributes of the sub-set of case-based documents. Based on the comparison, previously processed case-based documents, if any, which are found to be similar to the new case-based document are identified. | 03-07-2013 |
Jignesh Doshi, Pune IN
Patent application number | Description | Published |
---|---|---|
20140023614 | SUBSTITUTED FUSED TRICYCLIC COMPOUNDS, COMPOSITIONS AND MEDICINAL APPLICATIONS THEREOF - The present invention relates to substituted fused tricyclic compounds of formula (I) or (Ia), their tautomers, polymorphs, stereoisomers, prodrugs, solvates, co-crystals, pharmaceutically acceptable salts, pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by JAK activity. The compounds of the present invention are useful in the treatment, prevention or suppression of diseases and disorders mediated by JAK activity. Such conditions include, but not limited to, arthritis, Alzheimer's disease, autoimmune thyroid disorders, cancer, diabetes, leukemia, T-cell prolymphocytic leukemia, lymphoma, myleoproliferation disorders, lupus, multiple myeloma, multiple sclerosis, osteoarthritis, sepsis, psoriatic arthritis, prostate cancer, T-cell autoimmune disease, inflammatory diseases, chronic and acute allograft transplant rejection, bone marrow transplant, stroke, asthma, chronic obstructive pulmonary disease, allergy, bronchitis, viral diseases, or Type I diabetes, complications from diabetes, rheumatoid arthritis, asthma, Crohn's disease, dry eye, uveitis, inflammatory bowel disease, organ transplant rejection, psoriasis and ulcerative colitis. The present disclosure also relates to process for the preparation of such compounds, and to pharmaceutical compositions containing them. | 01-23-2014 |
Ketan Doshi, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20090249297 | Method and System for Automated Testing of Computer Applications - A system includes a testing device to test a computer application in conjunction with a testing tool, the testing device including a test automation engine to initiate a test, the test automation engine including a programmable data source that is testing tool universal, the programmable data source including one or more automation test scripts that define the test and a data storage device to store results from testing the computer application. | 10-01-2009 |
Manish Doshi, Surat IN
Patent application number | Description | Published |
---|---|---|
20130216719 | METHOD AND SYSTEM FOR COATING SUBSTRATES - The invention provides a method and apparatus for coating a substrate. The apparatus includes one or more enclosures positioned at an angle relative to a plane. Each enclosure is capable of receiving one or more substrates. The one or more enclosures include one or more inlets for receiving a coating fluid. The coating fluid flows in a pre-defined direction to coat the one or more substrates with the coating fluid. The one or more enclosures are positioned at the angle relative to the plane by one or more supporting structures and are dynamically adjustable to enable the flow of coating fluid in pre-defined direction. | 08-22-2013 |
20150079160 | NON-IMPLANTABLE MEDICAL DEVICE COATED WITH NANO-CARRIERS FOR DELIVERING ONE OR MORE DRUGS TO A BODY SITE - A drug-delivering medical device for delivering a drug to a target site in a human body is disclosed. The drug-delivering medical device may have a hydrophilic surface, with one or more portions of the hydrophilic surface coated with one or more nano-carriers bearing one or more drugs. Each nano-carrier may include a drug surrounded by an encapsulating medium. As the drug is surrounded by the encapsulating medium, the surface of each nano-carrier can be devoid of the respective drug. A non-implantable medical device coated with nano-carriers can deliver one or more drugs to a blood vessel, organ cavity, sac, capsule, lining, layer, coating, membrane, connective tissue, fluid surrounding an organ, and so forth. | 03-19-2015 |
20150086600 | RE-ESTABLISHMENT OF BLOOD FLOW IN BLOCKED HUMAN ARTERIES BY TRANSFERRING NANO-ENCAPSULATED DRUG THROUGH MEDICAL DEVICES, DESIGNED FOR THE SAME AND RELEASING THE NANO-ENCAPSULATED DRUG IN HUMAN ARTERY WITH BODY PH - A drug-delivering insertable medical device for treating a medical condition associated with a body lumen is disclosed. The drug-delivering insertable medical device includes an outer surface coated with two or more nano-carriers having two or more average diameters. A nano-carrier of the two or more nano-carriers has an average diameter suitable for penetrating one or more layers of two or more layers of the body lumen. The nano-carrier includes a drug surrounded by an encapsulating medium. The encapsulating medium includes one or more of a biological agent, a blood excipient, and a phospholipid. | 03-26-2015 |
Manish Doshi, Surat (gujarat) IN
Patent application number | Description | Published |
---|---|---|
20110264188 | RE-ESTABLISHMENT OF BLOOD FLOW IN BLOCKED HUMAN ARTERIES BY TRANSFERRING NANO-ENCAPSULATED DRUG THROUGH MEDICAL DEVICES, DESIGNED FOR THE SAME AND RELEASING THE NANO-ENCAPSULATED DRUG IN HUMAN ARTERY WITH BODY PH - A drug-delivering insertable medical device for treating a medical condition associated with a body lumen is disclosed. The drug-delivering insertable medical device includes an outer surface coated with two or more nano-carriers having two or more average diameters. A nano-carrier of the two or more nano-carriers has an average diameter suitable for penetrating one or more layers of two or more layers of the body lumen. The nano-carrier includes a drug surrounded by an encapsulating medium. The encapsulating medium includes one or more of a biological agent, a blood excipient, and a phospholipid. | 10-27-2011 |
20120065584 | REJUVENATING CORONARY ARTERY BY IMPROVING BLOOD FLOW WITH THE HELP OF INSERTION OF NANO-BALLS (ENCAPSULATED NANOPARTICLES) CONTAINING THERAPEUTIC AGENTS BY NON IMPLANTABLE DEVICE FOR TISSUES AND THEREBY PROVIDING IN TISSUE RELEASE TO ADDRESS THE REQUIRED CELL CYCLE - A drug-delivering medical device for delivering a drug to a target site in a body lumen is disclosed. The drug-delivering medical device includes a balloon catheter and an inflatable balloon positioned on the balloon catheter. The inflatable balloon has a hydrophilic surface. One or more portions of the hydrophilic surface are coated with two or more nano-carriers. A nano-carrier of the two or more nano-carriers includes a drug surrounded by an encapsulating medium. As the drug is surrounded by the encapsulating medium, the surface of the nano-carrier is devoid of the drug. When the inflatable balloon is inflated upon coming in proximity to a target site in the body lumen, about 30% to 80% of the two or more nano-carriers are released from the hydrophilic surface within 15-90 seconds. | 03-15-2012 |
20120276280 | METHOD AND SYSTEM FOR COATING INSERTABLE MEDICAL DEVICES - A coating system for coating an Insertable Medical Device (IMD) with one or more drugs is disclosed. The coating system includes a spray nozzle unit for coating the IMD with one or more drugs. The IMD includes a guiding member, a coating member and a supporting member. The IMD is passed through a protection tube such that the guiding member is located within the protection tube and an end of the supporting member is connected to a holder to expose the coating member of the IMD to the spray nozzle unit. The protection tube is received by a mandrel fixture which includes a circular disc for holding and rotating the protection tube and the IMD within the protection tube. When the protection tube along with the IMD is rotated, the spray nozzle unit coats the coating member of the IMD with the one or more drugs. | 11-01-2012 |
20120277726 | DRUG-ELUTING INSERTABLE MEDICAL DEVICE FOR TREATING ACUTE MYOCARDIAL INFARCTION, THROMBUS CONTAINING LESIONS AND SAPHENOUS-VEIN GRAFT LESIONS - A method for delivering at least one drug at a target site in a blood vessel for treating at least one of an acute myocardial infarction, a thrombus containing lesion and a saphenous-vein graft lesion is disclosed. The method includes delivering nano-carriers at the target site. The nano-carriers include one or more drugs encapsulated with a first biological agent. The nano-carriers further include a second biological agent in contact with one or more of the first biological agent and the one or more drugs. The first biological agent and the second biological agent have a first dissolution rate and a second dissolution rate respectively. The first dissolution rate is different from the second dissolution rate. The one or more drugs are released at the target site from the nano-carriers at a first release rate and a second release rate in response to dissolution of the first biological agent and the second biological agent, respectively. | 11-01-2012 |
20120277727 | METHOD AND AN INSERTABLE MEDICAL DEVICE FOR DELIVERING ONE OR MORE PRO-HEALING AGENTS TO A TARGET SITE WITHIN A BLOOD VESSEL POST-DEPLOYMENT OF A STENT - The invention discloses an insertable medical device for delivering one or more pro-healing agents to a site of deployment of a stent in a blood vessel. The surface of the insertable medical device is coated with nano-carriers that include the one or more pro-healing agents encapsulated with one or more biological agents. The nano-carriers are released when the insertable medical device is expanded at the site. The nano-carriers thus released penetrate tissues at the site resulting in dissolution of the one or more biological agents. Thereafter, the one or more pro-healing agents are released from the nano-carriers at the site. Thus, an in-tissue release of the one or more pro-healing agents at the site is achieved thereby improving endothealisation, extracellular matrix formation and healing at the site post deployment of the stent in the blood vessel. | 11-01-2012 |
20120283635 | METHOD AND A BALLOON CATHETER ASSEMBLY FOR TREATING BIFURCATION LESIONS - The invention discloses a balloon catheter assembly for delivering nano-carriers to bifurcation lesions in one or more of a main branch and a side branch of a blood vessel bifurcation within 30 to 90 seconds. The balloon catheter assembly includes two or more balloons designed for use in the blood vessel bifurcation. A surface of one or more of the two or more balloons is coated with the nano-carriers. The nano-carriers include one or more drugs encapsulated with one or more biological agents. | 11-08-2012 |
20120315300 | INSERTABLE MEDICAL DEVICES WITH A POROUS BED FOR DELIVERING NANO-CARRIERS TO A TARGET SITE AND METHODS OF PREPARING THE SAME - The invention discloses a method of coating a medical device. The method includes applying a coating composition on the medical device to form a layer on the medical device. The coating composition includes one or more of one or more biological agents and heparin dissolved in a mixture of a first solvent and a second solvent. The first solvent and the second solvent have different evaporation temperatures. Subsequently, at least a part of one of the first solvent and the second solvent present in the coating composition is evaporated to create a plurality of pores in the layer. Thereafter, one or more drugs are deposited in the plurality of pores. When the medical device is positioned and expanded at a target site, the one or more drugs are released from the plurality of pores. | 12-13-2012 |
20120321670 | FORMULATIONS OF NANO-CARRIERS AND METHODS OF PREPARING THE SAME - A method of preparing nano-carriers is disclosed. The method includes mixing an organic solution of a drug and an organic solution of a biological agent separately with a predetermined amount of water having one or more dissolved surfactants to obtain a first mixture and a second mixture respectively. Subsequently, the first mixture and the second mixture are homogenized separately to obtain a solution of nano-crystals of the drug and a solution of nano-particles of the biological agent respectively. Thereafter, the solution of nano-crystals of the drug and the solution of nano-particles of the biological agent are together subjected to an ultra-sound homogenization to obtain a solution of nano-carriers. An interfacial extraction and/or a dialysis are then performed on the solution of nano-carriers to obtain the nano-carriers. Formulations of the nano-carriers are also disclosed. | 12-20-2012 |
20140107615 | BIODEGRADABLE MEDICAL DEVICES AND METHOD TO CONTROL DEGRADATION OF THE BIODEGRADABLE MEDICAL DEVICES - An implantable biodegradable device having two or more layers composed of one or more biodegradable materials is disclosed. The two or more layers are coated with one or more drugs. The implantable biodegradable device further having one or more inert layers is composed of a biodegradable material. The one or more inert layers of the implantable biodegradable device are degraded in response to introduction of one or more external triggers when the implantable biodegradable medical device is placed within a living organism. Further, a layer of the two or more layers having a position above an inert layer is degraded prior to degradation of the inert layer. Subsequently, a layer of the two or more layers having a position below the inert layer is degraded subsequent to degradation of the inert layer. | 04-17-2014 |
20140142503 | METHOD AND A BALLOON CATHETER ASSEMBLY FOR TREATING BIFURCATION LESIONS - A balloon catheter assembly for delivering nano-carriers to bifurcation lesions in one or more of a main branch and a side branch of a blood vessel bifurcation within 30 to 90 seconds is provided. The balloon catheter assembly includes two or more balloons designed for use in the blood vessel bifurcation. The balloon catheter assembly may also include one or more stents. A surface of one or more of the two or more balloons is coated with the nano-carriers. Stents, when included, may also be coated with the nano-carriers. The nano-carriers include one or more drugs encapsulated with one or more biological agents. | 05-22-2014 |
Navin Doshi, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20090063389 | Comparison of Decision Logic - A request to compare strategies is received. The first strategy can be graphically represented by a first set of linked nodes arranged in a first form of decision logic. The second strategy can be graphically represented by a second set of linked nodes arranged in a second form of decision logic. The first set of linked nodes can be converted to a first modified set of linked nodes arranged in a third form of decision logic. The second set of linked nodes can be converted to a second modified set of linked nodes arranged in the third form of decision logic. A visual representation of the first modified set of linked nodes and the second modified set of linked nodes can be provided to a user. Related apparatus, techniques, and articles are also described. | 03-05-2009 |
20090064053 | Visualization of Decision Logic - Techniques for visualization of decision logic are provided. In one aspect, the techniques can be implemented by providing a control within a graphical user interface to a user. The control can display a plurality of graphical user interface elements corresponding to linked nodes within a hierarchical structure. An input identifying a selected graphical user interface element within the control can be generated by a user. A selected node within the hierarchical structure can be identified based on the selected graphical user interface element. In response to a request from a user, modifying an appearance of a subset of the linked nodes within the hierarchical structure based on a desired visualization criteria, the linked nodes within the hierarchical structure and the selected node. | 03-05-2009 |
20100060643 | Algorithm For Drawing Directed Acyclic Graphs - A system and method for drawing directed acyclic graphs is disclosed. In particular, an algorithm, as implemented in a method and system, to aesthetically layout directed acyclic graphs is presented. The algorithm includes methods to reduce the number of edge crossings and increase the number of straight edges in such drawings. The algorithm keeps short and straight edges wherever possible and gives preference to vertical edges. It also provides an edge-crossing reduction heuristic to refine the layout obtained after standard median heuristic layout, and further provides a method to focus on important paths in the graph through layout. | 03-11-2010 |
20100306167 | ARTICLE AND METHOD FOR FINDING A COMPACT REPRESENTATION TO VISUALIZE COMPLEX DECISION TREES - The invention comprises an article and method for transforming a complex or large decision tree having multiple variables; multiple values for each variable; and, multiple outcomes for each combination of variables and their associated values, into a compact, efficient graphical representation to provided enhanced ease of use and interaction by a human user. More particularly, the invention comprises a computationally efficient method for transforming an input decision tree into an optimal compact representation by computing a particular ordering of variables in the decision tree that first leads to a Directed Acyclic Graph, or “DAG,” with a minimum number of nodes. The method then converts the DAG into an exception-based DAG, or “EDAG,” with exactly one exception, having an optimal, minimum number of nodes with increased comprehensibility for a user. | 12-02-2010 |
20100332514 | DECISION LOGIC COMPARISON AND REVIEW - Techniques are described for logically comparing strategies. In one aspect the strategies can be compared by receiving a request to compare a first strategy to a second strategy, the first strategy graphically represented by a first set of linked nodes, the second strategy graphically represented by a second set of linked nodes, each set of linked nodes linking a root node to at least one action node; identifying a subset of linked nodes from at least one of the first set of linked nodes and the second set of linked nodes based on an equivalence of a first subset of the first set of linked nodes to a second subset of the second set of linked nodes; and, providing a visual depiction of the identified subset of the linked nodes to a user, the visual depiction corresponding to the equivalence of the first subset to the second subset. | 12-30-2010 |
Navin Doshi, Karnataka IN
Patent application number | Description | Published |
---|---|---|
20100060642 | Techniques For Drawing Curved Edges In Graphs - A system and method for drawing curved edges in graphs is disclosed. The system and method implement a heuristic algorithm to draw curved edges in graphs using Bezier curves. The algorithm assumes that every pair of nodes has a unique edge between them. It also assumes that the graph is “leveled,” which means the nodes can be grouped such that all the nodes in a group are laid out at the same y location in a vertical layout. Any generic graph can be converted to a leveled graph, so the techniques described in the algorithm are applicable to any graph. | 03-11-2010 |
Tejas Doshi, Ahmedabad IN
Patent application number | Description | Published |
---|---|---|
20130023710 | FCC CATALYST ADDITIVE AND A METHOD FOR ITS PREPARATION - The present invention relates to a Fluid Catalytic Cracking (FCC) additive preparation process and composition, which has high efficiency in the production of light olefins C2, C3 and C4 hydrocarbons, specifically propylene. The present invention discloses the stabilization of medium pore zeolite specifically ZSM-5 using optimum phosphate salts at a pH in the range 7-9 with synergetic combination of silica rich binder to produce FCC additive having excellent stability under severe hydrothermal conditions. | 01-24-2013 |
Vaibhav Chinubhai Doshi, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20080261959 | Novel crystalline forms of (S)-N-(1-Carboxy-2-methyl-prop-1-y)-N-pentanoyl-N[2'-(1H-tetrazol-5-yl)bi-phenyl-4-ylmethyl]-amine - This invention relates to novel crystalline forms of valsartan, namely Form A, Form B, Form C, Form D and their solvates thereof. Processes for the preparation of the novel forms are also provided. The present invention further relates to novel processes for preparing a stable amorphous form of valsartan, and in this connection, to the amorphous form of valsartan produced by such processes. The present invention also discloses a novel process for obtaining stable Form I crystals of valsartan. | 10-23-2008 |
20100081839 | PROCESS FOR PREPARATION OF CRYSTALLINE CLOPIDOGREL HYDROGEN SULPHATE FORM I - The present invention describes an improved industrial process for crystallizing out polymorph ‘Form I’ of (+) clopidogrel hydrogen sulphate (also called clopidogrel bisulphate) in) from either a Type-1 solvent or liquid characterized by comprising two or more functional groups or their mixtures thereof; or a Type-II solvent and/or solvent mixture selected from the group of methyl ethyl ketone, cyclopentylmethyl ether, dipropylglycolether, dibutylglycol ether, propylmethyl cellosolve, butylmethylcellosolve, propylethylellosolve, butylethylcellosolve or their cross combinations in a reproducible manner without detectable contamination of polymorph designated as ‘Form II’. The invention also discloses improvements in the preparation of clopidogrel free base and process for recovery and recycling of resolving agent camphor sulphonic acid. | 04-01-2010 |